ALK and neuroblastoma: R1275 accounts for 43% of ALK mutations in neuroblastoma, yet mutations at the F1174 locus (accounting for 30% of ALK mutations) are reported to have the strongest effect on nonphosphorylated ALK tyrosine kinase domain in vitro (Bresler et al., 2014).